【结 构 式】 |
【分子编号】63740 【品名】1-(4-piperidinyl)-1H-indole 【CA登记号】 |
【 分 子 式 】C13H16N2 【 分 子 量 】200.28352 【元素组成】C 77.96% H 8.05% N 13.99% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(II)Debenzylation of 1-benzyl-4-(1-indolyl)piperidine (I) with H2 and Pd(OH)2 leads to piperidine (II), which is further alkylated by 2-(bromomethyl)pyridine (III) to yield the pyridylmethyl piperidine (IV). Acylation of indole (IV) with oxalyl chloride produces the indoleglyoxylyl chloride (V). This is finally cyclized with the indolyl acetimidate (VI) in the presence of Et3N to produce the target bis-indolyl maleimide.
【1】 Heath, W.F.H. Jr.; McDonald, J.H. III; Paal, M.; Ruther, G.; Schotten, T.; Stenzel, W. (Eli Lilly and Company); Protein kinase C inhibitors. EP 0817627; JP 1997507066; US 5545636; WO 9517182 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 63739 | 1-(1-benzyl-4-piperidinyl)-1H-indole | C20H22N2 | 详情 | 详情 | |
(II) | 63740 | 1-(4-piperidinyl)-1H-indole | C13H16N2 | 详情 | 详情 | |
(III) | 27437 | 2-(bromomethyl)pyridine | C6H6BrN | 详情 | 详情 | |
(IV) | 63741 | 1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indole | C19H21N3 | 详情 | 详情 | |
(V) | 63742 | 2-oxo-2-{1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl}acetyl chloride | C21H20ClN3O2 | 详情 | 详情 | |
(VI) | 55755 | isopropyl 2-(1-methyl-1H-indol-3-yl)ethanimidoate | C14H18N2O | 详情 | 详情 |
Extended Information